BLBowen Liu

Bowen Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bowen Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Shi-Zhu Li

    Affiliation National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Center for Tropical Diseases Research, WHO Collaborating Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, Ministry of Health, Shanghai, China

    2 shared publications
  • Andong Xu

    National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China

    1 shared publication
  • Chao Lv

    School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

    1 shared publication
  • Duoquan Wang

    National Institute of Parasitic Diseases, Chinese Center for Disease Control and PreventionChinese Center for Tropical Diseases ResearchNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases; Key Laboratory of Parasite and Vector Biology, Ministry of HealthWHO Collaborating Centre for Tropical DiseasesNational Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai, 200025, China.

    1 shared publication
  • Jing-Bo Xue

    NHC Key Laboratory of Parasite and Vector Biology, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China

    1 shared publication
  • Muxin Chen

    National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    The re-emergence of psittacosis in China: a scoping review of epidemiology, diagnostics, and One Health priorities

    by Shiyi Huo, Wei Liu, Chao Lv, Bowen Liu, Jingbo Xue, Yang Hong, Yuwan Hao, Muxin Chen, Andong Xu, Xiao Tan, et al.

  • Open Access

    Profile and Determinants for Complications of Imported Malaria in 5 Chinese Provinces From 2014 to 2021: Retrospective Analysis

    by Bowen Liu, Tao Zhang, Duoquan Wang, Shang Xia, Weidong Li, Xiaoxi Zhang, Shuxun Wang, Xiao-Kui Guo, Xiao-Nong Zhou, Shizhu Li

    Background: In 2021, the World Health Organization officially declared the People’s Republic of China as malaria-free. However, despite this milestone achievement, the continued occurrence of severe and fatal cases of imported malaria in China, due to globalization and increased international communication, remains a significant public health concern. Objective: The aim of this study was to elucidate the epidemiological characteristics of imported malaria in 5 Chinese provinces from 2014 to 2021 and to identify the factors that influence complications in imported malaria cases. The findings will provide a basis for enhancing prevention and control measures, thereby consolidating China’s achievements in malaria elimination. Methods: A case-based retrospective study was performed, using surveillance data collected from the representative provinces of China from 2014 to 2021. Epidemiological characteristics were analyzed using descriptive statistics. Logistic regression was used to identify the factors influencing the occurrence of complications. Results: A total of 5559 malaria cases were included during the study period. The predominant species was Plasmodium falciparum (3940/5559, 70.9%), followed by Plasmodium ovale (1054/5559, 19%), Plasmodium vivax (407/5559, 7.3%), Plasmodium malariae (157/5559, 2.8%), and 1 case of Plasmodium knowlesi. Most of the cases were male (5343/5559, 96.1%). The complication rates for P falciparum and P ovale were 11.4% and 3.3%, respectively. Multivariate logistic regression analysis of the relevant factors of malaria complications revealed potential protective factors, including a previous infection by Plasmodium (P<.001; odds ratio [OR] 0.512, 95% CI 0.422‐0.621), and risk factors, including increased age (P=.004; OR 1.014, 95% CI 1.004‐1.024), misdiagnosis at the first clinical visit (P<.001; OR 3.553, 95% CI 2.886‐4.375), and the time interval from onset to treatment (P=.001; OR 1.026, 95% CI 1.011‐1.042). Subgroup analyses identified risk factors associated with P falciparum, which include advanced age (P=.004; OR 1.015, 95% CI 1.005‐1.026), initial misdiagnosis during the first clinical visit (P<.001; OR 3.549, 95% CI 2.827‐4.455), the time interval from onset to treatment (P<.001; OR 1.043, 95% CI 1.022‐1.063), and a delay of more than 3 days from the first treatment to diagnosis (P<.001; OR 2.403, 95% CI 1.823‐3.164). Additionally, the risk factors pertaining to P ovale involve misdiagnosis at the initial clinical visit (P=.01; OR 2.901, 95% CI 1.336‐6.298), the time interval from onset to treatment (P=.002; OR 1.095, 95% CI 1.033‐1.160), and the duration from the initial treatment to diagnosis (P=.43; OR 1.032, 95% CI 0.953‐1.118). Previous infections can prevent the progression of both P falciparum and P ovale. Conclusions: This study showed that the increasing proportion of P ovale in recent years should not be ignored. Furthermore, there is a need to improve diagnostic awareness, enhance the capacity of medical institutions, and provide health education for high-risk groups.